שולי רווח נקי GeoVax Labs, Inc. (GOVX)

Financial sales margins demonstrate historical profit dynamics, where 0.00 serves as the final level marker. GeoVax Labs, Inc. (GOVX) develops cancer and viral vaccines utilizing unique MVA technology. The specific nature of drug development renders the business independent of market fluctuations. The company's competitiveness is based on patents and the volume of government subsidies received.
פילוחי מדדים מקיפים ואנליטיקה עבור GeoVax Labs, Inc. (GOVX)

Protecting capital from market volatility requires a clear understanding of operational expenditure efficiency. Utilizing the MVA platform to combat cancer and infections allows GeoVax Labs, Inc. (GOVX) to optimize development costs. The net profit margin illustrates the portion of profit remaining after all expenses are deducted from revenue. The trend in this net profit margin reveals the business's ability to generate income. A stable indicator confirms the fundamental resilience of the asset within the portfolio.